博研生物抗體，“胰島素樣生長(zhǎng)因子結(jié)合蛋白2抗體,Anti-IGFBP2抗體*現(xiàn)貨”應(yīng)用于IHC、WB、 IF、IP、ELISA，質(zhì)量保證，無效免費(fèi)退換，另外本公司生產(chǎn)經(jīng)營(yíng)各種標(biāo)記二抗、免疫印跡常用試劑、免疫組化常用試劑，咨詢！

產(chǎn)品介紹：

【產(chǎn)品名稱】：胰島素樣生長(zhǎng)因子結(jié)合蛋白2抗體,Anti-IGFBP2抗體*現(xiàn)貨

【產(chǎn)品類型】：一抗

【產(chǎn)品編號(hào)】：BYk-1108R

【相關(guān)標(biāo)記】: HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647

【性 狀】： Lyophilized or Liquid

【濃 度】： 1mg/1ml

【亞 型】： IgG

【規(guī) 格】：0.1ml/100ug，0.2ml/200ug

【抗體來源】： Rabbit OR MOUSE

【克隆類型】： polyclonal or monoclonal

【產(chǎn)品用途】：科研實(shí)驗(yàn)，用于免疫組化實(shí)驗(yàn)，WB實(shí)驗(yàn)、IF、IP、ELISA實(shí)驗(yàn)，相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體，F(xiàn)ITC標(biāo)記，BIO等。

【貯 存】： Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

胰島素樣生長(zhǎng)因子結(jié)合蛋白2抗體,Anti-IGFBP2抗體*現(xiàn)貨【相關(guān)產(chǎn)品】：

Anti-PTGEs  前列腺素E合成酶抗體
Anti-PTHrP/PTHLH  甲狀旁腺激素相關(guān)蛋白抗體
Anti-PTN  多效生長(zhǎng)因子抗體
Anti-PTPRJ/CD148/DEP1  CD148抗體
Anti-PTP-1B  蛋白*磷酸酶-1B
Anti-Parvalbumin  微白蛋白/細(xì)小清蛋白抗體
Anti-PTTG  垂體腫瘤轉(zhuǎn)化基因抗體
Anti-Rad51  Rad51抗體
Anti-Rad52  Rad52抗體
Anti-RAD51C  乳腺癌和卵巢癌易感基因RAD51C抗體
anti-RAP1A   抗Rap1A抗體
Anti-phospho c-Raf  磷酸化原癌基因c-Raf抗體
Anti-RAR-α   維甲酸受體-α 抗體
Anti-RAR-β  維甲酸受體-β抗體
Anti-RASSF1A  Ras相關(guān)區(qū)域家族1A抗體
Anti-Pan-ras  抗Pan ras抗體
Anti-Rat IgA  大鼠IgA抗體
Anti-RELN  絡(luò)絲蛋白抗體
Anti-Rbms3 protein  Rbms3 protein抗體
Anti-Resistin  抵抗素抗體

【信息詳情】： IGFBP2 （insulin-like growth factor binding protein 2） is a member of the ISGBP family which bind various IGFs. IGFBP2 is overexpressed in a wide spectrum of other cancers, including glioma, prostate cancer, synovial sarcoma, neuroblastoma, colon cancer, adrenocortical cancer, lung cancer, Wilms' tumor, and hepatoblastoma. The overexpression of IGFBP2 also correlates with the aggressiveness of some tumors. IGFBP2 activates the expression of matrix metalloprotease 2, which contributes to cell invasiveness.